T1	Limited_variation	14 24	RB1 status
T2	Disease	55 65	TNBC cells
T3	Pharmacodynamic_phenotype	52 99	of TNBC cells to multiple other drugs including
T4	Pharmacodynamic_phenotype	100 111	cisplatin (
T5	Pharmacodynamic_phenotype	117 177	) , 5-fluorouracil , idarubicin , epirubicin , PRIMA-1 ( met
T6	Pharmacodynamic_phenotype	188 215	abine and PD-0332991 , some
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	influences	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T2	Arg2:T1
R7	influences	Arg1:T2	Arg2:T3
R8	isAssociatedWith	Arg1:T2	Arg2:T4
R9	isAssociatedWith	Arg1:T2	Arg2:T5
R10	isAssociatedWith	Arg1:T2	Arg2:T6
R11	isAssociatedWith	Arg1:T3	Arg2:T1
R12	treats	Arg1:T3	Arg2:T2
R13	treats	Arg1:T4	Arg2:T2
R14	treats	Arg1:T4	Arg2:T3
R15	treats	Arg1:T4	Arg2:T6
R16	treats	Arg1:T5	Arg2:T2
R17	isEquivalentTo	Arg1:T5	Arg2:T4
R18	treats	Arg1:T6	Arg2:T2
